Connection

Igor Roninson to Neoplasms

This is a "connection" page, showing publications Igor Roninson has written about Neoplasms.
Connection Strength

1.458
  1. Identifying Cancers Impacted by CDK8/19. Cells. 2019 08 03; 8(8).
    View in: PubMed
    Score: 0.298
  2. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13799-804.
    View in: PubMed
    Score: 0.183
  3. A subunit of coatomer protein complex offers a novel tumor-specific target through a surprising mechanism. Autophagy. 2011 Dec; 7(12):1551-2.
    View in: PubMed
    Score: 0.175
  4. Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ? 2 renders tumor cells dependent on its paralogous gene COPZ1. Proc Natl Acad Sci U S A. 2011 Jul 26; 108(30):12449-54.
    View in: PubMed
    Score: 0.170
  5. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene. 2004 Apr 12; 23(16):2919-33.
    View in: PubMed
    Score: 0.103
  6. Tumor cell senescence in cancer treatment. Cancer Res. 2003 Jun 01; 63(11):2705-15.
    View in: PubMed
    Score: 0.097
  7. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):389-94.
    View in: PubMed
    Score: 0.088
  8. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat. 2001 Oct; 4(5):303-13.
    View in: PubMed
    Score: 0.086
  9. Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res. 1995 Sep 15; 55(18):4023-8.
    View in: PubMed
    Score: 0.057
  10. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 09; 87(18):7160-4.
    View in: PubMed
    Score: 0.040
  11. Molecular mechanism of multidrug resistance in tumor cells. Clin Physiol Biochem. 1987; 5(3-4):140-51.
    View in: PubMed
    Score: 0.031
  12. The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med. 2007 Jan; 13(1):4-11.
    View in: PubMed
    Score: 0.031
  13. Seeking favors from nature. Cancer Biol Ther. 2005 Jul; 4(7):794-9.
    View in: PubMed
    Score: 0.028
  14. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002 May 08; 179(1):1-14.
    View in: PubMed
    Score: 0.023
  15. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. Int J Cancer. 1996 Oct 09; 68(2):245-50.
    View in: PubMed
    Score: 0.015
  16. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat Cell Biol. 2016 07; 18(7):777-89.
    View in: PubMed
    Score: 0.015
  17. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 07; 47(3):381-9.
    View in: PubMed
    Score: 0.008
  18. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 1986 May 02; 232(4750):643-5.
    View in: PubMed
    Score: 0.007
  19. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun. 1986 Dec 30; 141(3):956-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.